Rhumbline Advisers lowered its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 2.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 251,316 shares of the health services provider’s stock after selling 6,693 shares during the quarter. Rhumbline Advisers owned 0.19% of Select Medical worth $4,624,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently bought and sold shares of the business. SG Americas Securities LLC lifted its position in shares of Select Medical by 232.9% during the 3rd quarter. SG Americas Securities LLC now owns 98,369 shares of the health services provider’s stock worth $1,810,000 after buying an additional 68,816 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Select Medical by 14.8% during the 3rd quarter. Victory Capital Management Inc. now owns 2,094,711 shares of the health services provider’s stock worth $38,543,000 after buying an additional 270,498 shares in the last quarter. Legacy Financial Advisors Inc. bought a new position in shares of Select Medical during the 3rd quarter worth approximately $142,000. Mesirow Financial Investment Management Equity Management bought a new position in shares of Select Medical during the 3rd quarter worth approximately $16,312,000. Finally, Public Employees Retirement Association of Colorado lifted its position in shares of Select Medical by 232.4% during the 3rd quarter. Public Employees Retirement Association of Colorado now owns 11,155 shares of the health services provider’s stock worth $205,000 after buying an additional 7,799 shares in the last quarter. 75.45% of the stock is currently owned by hedge funds and other institutional investors.
NYSE:SEM opened at $18.41 on Friday. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 3.72. The company has a market capitalization of $2.52 billion, a P/E ratio of 16.31, a P/E/G ratio of 1.26 and a beta of 1.43. Select Medical Holdings Co. has a 12 month low of $15.83 and a 12 month high of $21.65.
Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, November 1st. The health services provider reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.28 billion. Select Medical had a net margin of 4.32% and a return on equity of 15.95%. Select Medical’s revenue was up 17.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.14 EPS. As a group, sell-side analysts expect that Select Medical Holdings Co. will post 1.05 EPS for the current year.
SEM has been the topic of several recent analyst reports. Credit Suisse Group lifted their target price on shares of Select Medical from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, November 5th. ValuEngine cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, September 12th. Finally, Zacks Investment Research raised shares of Select Medical from a “sell” rating to a “hold” rating in a research report on Thursday, October 4th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Select Medical presently has a consensus rating of “Hold” and an average price target of $20.83.
In related news, Chairman Robert A. Ortenzio sold 37,468 shares of Select Medical stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $20.05, for a total value of $751,233.40. Following the sale, the chairman now owns 7,251,571 shares of the company’s stock, valued at approximately $145,393,998.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Robert A. Ortenzio sold 98,576 shares of Select Medical stock in a transaction that occurred on Thursday, November 8th. The stock was sold at an average price of $20.05, for a total transaction of $1,976,448.80. Following the completion of the sale, the chairman now directly owns 7,251,571 shares in the company, valued at approximately $145,393,998.55. The disclosure for this sale can be found here. Insiders sold a total of 145,044 shares of company stock worth $2,907,682 in the last ninety days. 19.86% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/12/08/select-medical-holdings-co-sem-holdings-lowered-by-rhumbline-advisers.html.
About Select Medical
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Featured Article: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.